BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28247269)

  • 1. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
    de Almeida SM; Rotta I; Ribeiro CE; Oliveira MF; Chaillon A; de Pereira AP; Cunha AP; Zonta M; Bents JF; Raboni SM; Smith D; Letendre S; Ellis RJ
    J Neurovirol; 2017 Jun; 23(3):460-473. PubMed ID: 28247269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.
    Adewumi OM; Dukhovlinova E; Shehu NY; Zhou S; Council OD; Akanbi MO; Taiwo B; Ogunniyi A; Robertson K; Kanyama C; Hosseinipour MC; Swanstrom R
    AIDS Res Hum Retroviruses; 2020 Jun; 36(6):490-500. PubMed ID: 31914800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
    Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
    PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
    Oliveira MF; Chaillon A; Nakazawa M; Vargas M; Letendre SL; Strain MC; Ellis RJ; Morris S; Little SJ; Smith DM; Gianella S
    PLoS Pathog; 2017 Jan; 13(1):e1006112. PubMed ID: 28046096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.
    de Almeida SM; Rotta I; Jiang Y; Li X; Raboni SM; Ribeiro CE; Smith D; Potter M; Vaida F; Letendre S; Ellis RJ;
    J Neurovirol; 2016 Dec; 22(6):715-724. PubMed ID: 27400932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children.
    Sturdevant CB; Dow A; Jabara CB; Joseph SB; Schnell G; Takamune N; Mallewa M; Heyderman RS; Van Rie A; Swanstrom R
    PLoS Pathog; 2012 Dec; 8(12):e1003094. PubMed ID: 23300446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.
    Sturdevant CB; Joseph SB; Schnell G; Price RW; Swanstrom R; Spudich S
    PLoS Pathog; 2015 Mar; 11(3):e1004720. PubMed ID: 25811757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
    Joseph SB; Trunfio M; Kincer LP; Calcagno A; Price RW
    AIDS; 2019 Dec; 33 Suppl 2():S171-S179. PubMed ID: 31790378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.
    de Almeida SM; Oliveira MF; Chaillon A; Rotta I; Ribeiro CE; de Pereira AP; Smith D; Letendre S; Ellis RJ
    J Neurovirol; 2018 Dec; 24(6):786-796. PubMed ID: 30194587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties.
    Stefic K; Chaillon A; Bouvin-Pley M; Moreau A; Braibant M; Bastides F; Gras G; Bernard L; Barin F
    PLoS One; 2017; 12(8):e0181680. PubMed ID: 28841647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.
    de Almeida SM; Rotta I; Ribeiro CE; Smith D; Wang R; Judicello J; Potter M; Vaida F; Letendre S; Ellis RJ;
    J Neuroimmunol; 2016 Dec; 301():41-48. PubMed ID: 27836178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.
    Cinque P; Bestetti A; Morelli P; Presi S
    J Neurovirol; 2000 May; 6 Suppl 1():S95-S102. PubMed ID: 10871772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
    Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
    Premeaux TA; D'Antoni ML; Abdel-Mohsen M; Pillai SK; Kallianpur KJ; Nakamoto BK; Agsalda-Garcia M; Shiramizu B; Shikuma CM; Gisslén M; Price RW; Valcour V; Ndhlovu LC
    J Neurovirol; 2019 Apr; 25(2):150-161. PubMed ID: 30478799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
    Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew B; Fuchs D; Tambussi G; Cinque P; Hecht FM; Price RW
    J Infect Dis; 2011 Sep; 204(5):753-60. PubMed ID: 21844301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic attributes of cerebrospinal fluid-derived HIV-1 env.
    Pillai SK; Pond SL; Liu Y; Good BM; Strain MC; Ellis RJ; Letendre S; Smith DM; Günthard HF; Grant I; Marcotte TD; McCutchan JA; Richman DD; Wong JK
    Brain; 2006 Jul; 129(Pt 7):1872-83. PubMed ID: 16735456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.
    Antinori A; Giancola ML; Grisetti S; Soldani F; Alba L; Liuzzi G; Amendola A; Capobianchi M; Tozzi V; Perno CF
    AIDS; 2002 Sep; 16(14):1867-76. PubMed ID: 12351946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.
    Bingham R; Ahmed N; Rangi P; Johnson M; Tyrer M; Green J
    Int J STD AIDS; 2011 Oct; 22(10):608-9. PubMed ID: 21998185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.